Printed from https://ideas.repec.org/s/sae/medema6.html
Content
February 2014, Volume 34, Issue 2
- 258-269 Surrogate Decision Making
by Renato Frey & Ralph Hertwig & Stefan M. Herzog
January 2014, Volume 34, Issue 1
- 4-7 Moments When Utilities Are Functional
by Stephen G. Pauker - 8-20 Comparing EQ-5D Valuation Studies
by Feng Xie & Kathryn Gaebel & Kuhan Perampaladas & Brett Doble & Eleanor Pullenayegum - 21-32 Health Status Utilities in Pediatrics
by Raphaële R. L. van Litsenburg & Annemieke Kunst & Jaap Huisman & Johannes C. F. Ket & Gertjan J. L. Kaspers & Reinoud J. B. J. Gemke - 33-41 Risk Preferences
by Stefan Felder & Thomas Mayrhofer - 42-53 Effect of Adding a Sleep Dimension to the EQ-5D Descriptive System
by Yaling Yang & John Brazier & Aki Tsuchiya - 54-62 Validation of SURE, a Four-Item Clinical Checklist for Detecting Decisional Conflict in Patients
by Audrey Ferron Parayre & Michel Labrecque & Michel Rousseau & Stéphane Turcotte & France Légaré - 63-74 Physicians’ Tacit and Stated Policies for Determining Patient Benefit and Referral to Cardiac Rehabilitation
by Jason W. Beckstead & Mark V. Pezzo & Theresa M. Beckie & Farnaz Shahraki & Amanda C. Kentner & Sherry L. Grace - 75-83 Exploring the Impact of Expertise, Clinical History, and Visual Search on Electrocardiogram Interpretation
by Greg Wood & Jeremy Batt & Andrew Appelboam & Adrian Harris & Mark R. Wilson - 84-96 A Discrete Choice Experiment to Obtain a Tariff for Valuing Informal Care Situations Measured with the CarerQol Instrument
by Renske J. Hoefman & Job van Exel & John M. Rose & E. J. van de Wetering & Werner B. F. Brouwer - 97-106 Content Coding for Contextualization of Care
by Saul J. Weiner & Brendan Kelly & Naomi Ashley & Amy Binns-Calvey & Gunjan Sharma & Alan Schwartz & Frances M. Weaver - 107-115 Health Numeracy
by Helen Levy & Peter A. Ubel & Amanda J. Dillard & David R. Weir & Angela Fagerlin - 116-126 Participation in Cancer Clinical Trials
by Margaret M. Byrne & Stacey L. Tannenbaum & Stefan Glück & Judith Hurley & Michael Antoni - 127-137 Exploring the Validity of HPQ-Based Presenteeism Measures to Estimate Productivity Losses in the Health and Education Sectors
by Paul A. Scuffham & Nerina Vecchio & Harvey A. Whiteford
November 2013, Volume 33, Issue 8
- 976-985 Estimating the Cost of No-Shows and Evaluating the Effects of Mitigation Strategies
by Bjorn P. Berg & Michael Murr & David Chermak & Jonathan Woodall & Michael Pignone & Robert S. Sandler & Brian T. Denton - 986-997 Accounting for Costs, QALYs, and Capacity Constraints
by Glenis J. Crane & Steven M. Kymes & Janet E. Hiller & Robert Casson & Adam Martin & Jonathan D. Karnon - 998-1008 Continuous versus Intermittent Data Collection of Health Care Utilization
by Marike R. C. Hendriks & Maiwenn J. Al & Michel H. C. Bleijlevens & Jolanda C. M. van Haastregt & Harry F. J. M. Crebolder & Jacques Th. M. van Eijk & Silvia M. A. A. Evers - 1009-1025 Link between Process and Appraisal in Coverage Decisions
by Katharina E. Fischer & Björn Stollenwerk & Wolf H. Rogowski - 1026-1038 Vaccination, Herd Behavior, and Herd Immunity
by Matan J. Cohen & Mayer Brezis & Colin Block & Adele Diederich & David Chinitz - 1039-1050 Applying the Payoff Time Framework to Carotid Artery Disease Management
by Theodore H. Yuo & Mark S. Roberts & R. Scott Braithwaite & Chung-Chou H. Chang & Kevin L. Kraemer - 1051-1063 Multiple Imputation Methods for Handling Missing Data in Cost-effectiveness Analyses That Use Data from Hierarchical Studies
by Manuel Gomes & Karla DÃaz-Ordaz & Richard Grieve & Michael G. Kenward
October 2013, Volume 33, Issue 7
- 880-890 Linear Regression Metamodeling as a Tool to Summarize and Present Simulation Model Results
by Hawre Jalal & Bryan Dowd & François Sainfort & Karen M. Kuntz - 891-905 Medical Therapy v. PCI in Stable Coronary Artery Disease
by Harindra C. Wijeysundera & George Tomlinson & Dennis T. Ko & Vladimir Dzavik & Murray D. Krahn - 906-919 Management of Undescended Testis
by M. Elske van den Akker–van Marle & Mascha Kamphuis & Helma B. M. van Gameren–Oosterom & Frank H. Pierik & Job Kievit - 920-936 Too Much of a Good Thing? When to Stop Catch-Up Vaccination
by David W. Hutton & Margaret L. Brandeau - 937-948 Nutritional Policy Changes in the Supplemental Nutrition Assistance Program
by Sanjay Basu & Hilary Seligman & Jay Bhattacharya - 949-960 Sequential Value-of-Information Assessment for Prospective Drug Safety Monitoring Using Claims Databases
by Amanda R. Patrick & Jessica M. Franklin & Milton C. Weinstein & Robert J. Glynn & Sebastian Schneeweiss - 961-970 The Half-Cycle Correction Revisited
by David M. J. Naimark & Nader N. Kabboul & Murray D. Krahn
August 2013, Volume 33, Issue 6
- 740-742 Extrapolation of Survival Data in Cost-effectiveness Analyses
by Richard Grieve & Neil Hawkins & Mark Pennington - 743-754 Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data
by Nicholas R. Latimer - 755-766 An Efficient Method for Computing Single-Parameter Partial Expected Value of Perfect Information
by Mark Strong & Jeremy E. Oakley - 767-779 A Mathematical Approach for Evaluating Markov Models in Continuous Time without Discrete-Event Simulation
by Joost van Rosmalen & Mehlika Toy & James F. O’Mahony - 780-792 Development of a Framework for Cohort Simulation in Cost-Effectiveness Analyses Using a Multistep Ordinary Differential Equation Solver Algorithm in R
by Gerardus W. J. Frederix & Johan G. C. van Hasselt & Johan L. Severens & Anke M. Hövels & Alwin D. R. Huitema & Jan A. M. Raaijmakers & Jan H. M. Schellens - 793-803 US Valuation of the SF-6D
by Benjamin M. Craig & A. Simon Pickard & Elly Stolk & John E. Brazier - 804-818 Hospital Variation in Patient-Reported Outcomes at the Level of EQ-5D Dimensions
by Nils Gutacker & Chris Bojke & Silvio Daidone & Nancy Devlin & Andrew Street - 819-838 Patient and Societal Value Functions for the Testing Morbidities Index
by J. Shannon Swan & Chung Yin Kong & Janie M. Lee & Omosalewa Itauma & Elkan F. Halpern & Pablo A. Lee & Sergey Vavinskiy & Olubunmi Williams & Emilie S. Zoltick & Karen Donelan - 839-852 Common Scale Valuations across Different Preference-Based Measures
by Mónica Hernández Alava & John Brazier & Donna Rowen & Aki Tsuchiya - 853-859 Expressing Death Risk as Condensed Life Experience and Death Intensity
by John P. A. Ioannidis - 860-868 Continuously Rethinking the Definition of Influenza for Surveillance Systems
by Farrokh Alemi & Martin J. Atherton & David C. Pattie & Manabu Torii - 869-874 Sufficiently Important Difference
by Bruce Barrett
July 2013, Volume 33, Issue 5
- 597-606 Evidence Synthesis for Decision Making 1
by Sofia Dias & Nicky J. Welton & Alex J. Sutton & A. E. Ades - 607-617 Evidence Synthesis for Decision Making 2
by Sofia Dias & Alex J. Sutton & A. E. Ades & Nicky J. Welton - 618-640 Evidence Synthesis for Decision Making 3
by Sofia Dias & Alex J. Sutton & Nicky J. Welton & A. E. Ades - 641-656 Evidence Synthesis for Decision Making 4
by Sofia Dias & Nicky J. Welton & Alex J. Sutton & Deborah M. Caldwell & Guobing Lu & A. E. Ades - 657-670 Evidence Synthesis for Decision Making 5
by Sofia Dias & Nicky J. Welton & Alex J. Sutton & A. E. Ades - 671-678 Evidence Synthesis for Decision Making 6
by Sofia Dias & Alex J. Sutton & Nicky J. Welton & A. E. Ades - 692-701 Bivariate Random-Effects Meta-analysis of Sensitivity and Specificity with the Bayesian SAS PROC MCMC
by Jan Menke - 702-714 Comparing Bayesian and Frequentist Approaches for Multiple Outcome Mixed Treatment Comparisons
by Hwanhee Hong & Bradley P. Carlin & Tatyana A. Shamliyan & Jean F. Wyman & Rema Ramakrishnan & François Sainfort & Robert L. Kane - 715-730 Use of Multiparameter Evidence Synthesis to Assess the Appropriateness of Data and Structure in Decision Models
by David Epstein & Leticia GarcÃa Mochón & Jaime EspÃn & Marta O. Soares - 731-733 In Memoriam
by Shikhar Shah & J. Robert Beck & Stephen G. Pauker
May 2013, Volume 33, Issue 4
- 457-459 The Value of HIV Screening in the United States in the Era of Effective Treatment
by Bruce R. Schackman - 460-462 Toward a Science of Research Prioritization? The Use of Value of Information by Multidisciplinary Stakeholder Groups
by Rachael L. Fleurence & David O. Meltzer - 463-471 Value-of-Information Analysis within a Stakeholder-Driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics
by Josh J. Carlson & Rahber Thariani & Josh Roth & Julie Gralow & N. Lynn Henry & Laura Esmail & Pat Deverka & Scott D. Ramsey & Laurence Baker & David L. Veenstra - 472-489 The Role of Value-of-Information Analysis in a Health Care Research Priority Setting
by Isaac Corro Ramos & Maureen P. M. H. Rutten-van Mölken & Maiwenn J. Al - 490-501 Evaluation of Markers and Risk Prediction Models
by Ben Van Calster & Andrew J. Vickers & Michael J. Pencina & Stuart G. Baker & Dirk Timmerman & Ewout W. Steyerberg - 502-509 Rating the Preferences for Potential Harms of Treatments for Cardiovascular Disease
by Guangxiang Zhang & Puja B. Parikh & Soraya Zabihi & David L. Brown - 510-520 Estimating the Relative Utility of Screening Mammography
by Craig K. Abbey & Miguel P. Eckstein & John M. Boone - 521-532 Cost-Effectiveness of Adjuvant FOLFOX and 5FU/LV Chemotherapy for Patients with Stage II Colon Cancer
by Mehmet U. S. Ayvaci & Jinghua Shi & Oguzhan Alagoz & Sam J. Lubner - 533-543 Correlates of Diagnostic Accuracy in Patients with Nonspecific Complaints
by Ralph Hertwig & Nathalie Meier & Christian Nickel & Pia-Cristina Zimmermann & Selina Ackermann & Jan K. Woike & Roland Bingisser - 544-546 A Note on the Expected Biases in Conventional Iterative Health State Valuation Protocols
by Laura Ternent & Aki Tsuchiya - 547-557 Predicting the ICECAP-O Capability Index from the WOMAC Osteoarthritis Index
by Paul M. Mitchell & Tracy E. Roberts & Pelham M. Barton & Beth S. Pollard & Joanna Coast - 558-566 Prediction of Health Preference Values from CD4 Counts in Individuals with HIV
by Pierre K. Isogai & Sergio Rueda & Anita R. Rachlis & Sean B. Rourke & Nicole Mittmann - 567-578 Scoring the 5-Level EQ-5D
by Eleanor Pullenayegum & Feng Xie - 579-592 Risk Perception of Prescription Drugs
by Andrea R. Beyer & Barbara Fasolo & Lawrence D. Phillips & Pieter A. de Graeff & Hans L. Hillege
April 2013, Volume 33, Issue 3
- 313-315 Methods Development for Health Technology Assessment
by Mark Sculpher - 316-319 Standardization and Regulatory Guidelines May Inhibit Science and Reduce the Usefulness of Analyses Based on the Application of Preference-Based Measures for Policy Decisions
by David Feeny - 320-324 At the Center of Health Care Policy Making
by Andrew J. Stevens & Carole Longson - 325-332 Improving the Accuracy and Comparability of Model-Based Economic Evaluations of Health Technologies for Reimbursement Decisions
by Hossein Haji Ali Afzali & Jonathan Karnon & Tracy Merlin - 333-342 Assessing Personalized Medicines in Australia
by Tracy Merlin & Claude Farah & Camille Schubert & Andrew Mitchell & Janet E. Hiller & Philip Ryan - 343-355 A Pilot Study Using Machine Learning and Domain Knowledge to Facilitate Comparative Effectiveness Review Updating
by Siddhartha R. Dalal & Paul G. Shekelle & Susanne Hempel & Sydne J. Newberry & Aneesa Motala & Kanaka D. Shetty - 356-368 The Choice of a Noninformative Prior on Between-Study Variance Strongly Affects Predictions of Future Treatment Effect
by Olga Gajic-Veljanoski & Angela M. Cheung & Ahmed M. Bayoumi & George Tomlinson - 369-380 The “Hazards†of Extrapolating Survival Curves
by Charlotte Davies & Andrew Briggs & Paula Lorgelly & Göran Garellick & Henrik Malchau - 381-395 Estimating a Preference-Based Index from the Clinical Outcomes in Routine Evaluation–Outcome Measure (CORE-OM)
by Ifigeneia Mavranezouli & John E. Brazier & Donna Rowen & Michael Barkham - 396-406 Identifying Individual Changes in Performance With Composite Quality Indicators While Accounting for Regression to the Mean
by Byron J. Gajewski & Nancy Dunton - 407-414 Multicohort Models in Cost-Effectiveness Analysis
by James F. O’Mahony & Joost van Rosmalen & Ann G. Zauber & Marjolein van Ballegooijen - 415-436 Methods to Assess Cost-Effectiveness and Value of Further Research When Data Are Sparse
by Marta O. Soares & Jo C. Dumville & Rebecca L. Ashby & Cynthia P. Iglesias & Laura Bojke & Una Adderley & Elizabeth McGinnis & Nikki Stubbs & David J. Torgerson & Karl Claxton & Nicky Cullum - 437-450 The Impact of Using Informative Priors in a Bayesian Cost-Effectiveness Analysis
by C. Elizabeth McCarron & Eleanor M. Pullenayegum & Lehana Thabane & Ron Goeree & Jean-Eric Tarride
February 2013, Volume 33, Issue 2
- 1-137 34th Annual Meeting for the Society for Medical Decision Making
by N/A - 125-132 Thank You to the Reviewers of 2012
by N/A - 133-135 Probability Distributions
by Stephen G. Pauker - 136-138 An Inquiry About Clinicians’ View of the Distribution of Posttest Probabilities
by Jef Van den Ende & Juan Moreira & Lisine Tuyisenge & Zeno Bisoffi - 138-144 Author Index For Abstracts
by N/A - 139-153 Estimating Health State Utility Values for Joint Health Conditions
by Roberta Ara & Allan J. Wailoo - 145-203 14th Biennial European Meeting of the Society for Medical Decision Making
by N/A - 154-162 A Bias-Corrected Net Reclassification Improvement for Clinical Subgroups
by Nina P. Paynter & Nancy R. Cook - 163-175 The Utility of Childhood and Adolescent Obesity Assessment in Relation to Adult Health
by Jeremy D. Goldhaber-Fiebert & Rachel E. Rubinfeld & Jay Bhattacharya & Thomas N. Robinson & Paul H. Wise - 176-197 Derivation of Background Mortality by Smoking and Obesity in Cancer Simulation Models
by Y. Claire Wang & Barry I. Graubard & Marjorie A. Rosenberg & Karen M. Kuntz & Ann G. Zauber & Lisa Kahle & Clyde B. Schechter & Eric J. Feuer - 198-214 Comparison of Surveillance Strategies for Low-Risk Bladder Cancer Patients
by Yuan Zhang & Brian T. Denton & Matthew E. Nielsen - 215-224 Patient Time Costs Associated with Sensor-Augmented Insulin Pump Therapy for Type 1 Diabetes
by Shital Kamble & Kevin P. Weinfurt & Kevin A. Schulman & Shelby D. Reed - 225-234 Are Standard Diagnostic Test Characteristics Sufficient for the Assessment of Continual Patient Monitoring?
by Liangyou Chen & Andrew T. Reisner & Xiaoxiao Chen & Andrei Gribok & Jaques Reifman - 235-243 Evidence of Spillover of Illness among Household Members
by Eve Wittenberg & Grant A. Ritter & Lisa A. Prosser - 244-251 Generalized Additive Models for the Analysis of EQ-5D Utility Data
by Eleanor M. Pullenayegum & Hoi Suen Wong & Aaron Childs - 252-260 Testing for Differential Item Functioning within the EQ-5D
by David K. Whynes & Nikola Sprigg & James Selby & Eivind Berge & Philip M. Bath - 261-270 The Impact of Patients’ Subjective Life Expectancy on Time Tradeoff Valuations
by Emelie Heintz & Marieke Krol & Lars-Åke Levin - 271-281 “Don’t Know†Responses to Risk Perception Measures
by Erika A. Waters & Jennifer L. Hay & Heather Orom & Marc T. Kiviniemi & Bettina F. Drake - 282-297 Use of Natural Health Products
by Heather Boon & Natasha Kachan & Andreas Boecker - 298-306 Identification of a Multistate Continuous-Time Nonhomogeneous Markov Chain Model for Patients with Decreased Renal Function
by Alexander Begun & Andrea Icks & Regina Waldeyer & Sandra Landwehr & Michael Koch & Guido Giani - 307-307 Corrigendum
by N/A
January 2013, Volume 33, Issue 1
- 4-13 All Stories Are Not Alike
by Victoria A. Shaffer & Brian J. Zikmund-Fisher - 14-25 Effect of Narrative Reports about Vaccine Adverse Events and Bias-Awareness Disclaimers on Vaccine Decisions
by Cornelia Betsch & Frank Renkewitz & Niels Haase - 26-36 Patients’ Experiences of Shared Decision Making in Primary Care Practices in the United Kingdom
by Catherine Fullwood & Anne Kennedy & Anne Rogers & Martin Eden & Caroline Gardner & Joanne Protheroe & David Reeves - 37-47 When Decisions Should Be Shared
by Meike Müller-Engelmann & Norbert Donner-Banzhoff & Heidi Keller & Lydia Rosinger & Carsten Sauer & Kerstin Rehfeldt & Tanja Krones - 48-58 Using Comparison Scenarios to Improve Prenatal Risk Communication
by Stefania Pighin & Lucia Savadori & Elisa Barilli & Rino Rumiati & Sara Bonalumi & Maurizio Ferrari & Laura Cremonesi - 59-70 Patients’ Preferences and Priorities Regarding Colorectal Cancer Screening
by James G. Dolan & Emily Boohaker & Jeroan Allison & Thomas F. Imperiale - 71-77 On Averages and Peaks
by Shoshana Shiloh & Christopher H. Wade & J. Scott Roberts & Sharon Hensley Alford & Barbara B. Biesecker - 78-84 Interpreting Patient Decisional Conflict Scores
by Anouk M. Knops & Astrid Goossens & Dirk T. Ubbink & Dink A. Legemate & Lukas J. Stalpers & Patrick M. Bossuyt - 85-97 Incorporating Patient Decision Aids into Standard Clinical Practice in an Integrated Delivery System
by Clarissa Hsu & David T. Liss & Emily O. Westbrook & David Arterburn - 98-107 How to Discriminate between Computer-Aided and Computer-Hindered Decisions
by Andrey A. Povyakalo & Eugenio Alberdi & Lorenzo Strigini & Peter Ayton - 108-118 Why Do Patients Derogate Physicians Who Use a Computer-Based Diagnostic Support System?
by Victoria A. Shaffer & C. Adam Probst & Edgar C. Merkle & Hal R. Arkes & Mitchell A. Medow
November 2012, Volume 32, Issue 6
- 1-15 Quantitative Benefit-Risk Assessment Using Only Qualitative Information on Utilities
by Ola Caster & G. Niklas Norén & Love Ekenberg & I. Ralph Edwards - 16-34 Does Introduction of Thresholds in Decision Aids Benefit the Patient?
by Bettina Bisig & Juan Moreira & Mattieu Combes & Anita Asiimwe & Zeno Bisoffi & Frank Haegeman & Emmanuel Bottieau & Jef Van den Ende - 749-749 Quantitative Benefit-Risk Assessment Using Only Qualitative Information on Utilities
by Ola Caster & G. Niklas Norén & Love Ekenberg & I. Ralph Edwards & Bettina Bisig & Juan Moreira & Mattieu Combes & Anita Asiimwe & Zeno Bisoffi & Frank Haegeman & Emmanuel Bottieau & Jef Van den Ende - 750-763 Methods for Estimating Subgroup Effects in Cost-Effectiveness Analyses That Use Observational Data
by Noemi Kreif & Richard Grieve & Rosalba Radice & Zia Sadique & Roland Ramsahai & Jasjeet S. Sekhon - 764-778 Choosing between Hospitals
by I. B. de Groot & W. Otten & J. Dijs-Elsinga & H. J. Smeets & J. Kievit & P. J. Marang-van de Mheen - 779-791 Effectiveness of a Decision-Training Aid on Referral Prioritization Capacity
by Priscilla Harries & Christopher Tomlinson & Elizabeth Notley & Miranda Davies & Kenneth Gilhooly - 792-804 Simple and Multistate Survival Curves
by Tim Rakow & Rebecca J. Wright & Catherine Bull & David J. Spiegelhalter - 805-814 The Influence of Time and Adaptation on Health State Valuations in Patients With Spinal Cord Injury
by Yvette Edelaar-Peeters & Hein Putter & Govert J. Snoek & Tebbe A. R. Sluis & Christof A. J. Smit & Marcel W. M. Post & Anne M. Stiggelbout - 815-819 The Context of Available Options Affects Health Care Decisions
by Florence Dumas & Michel Gonzalez & Vittorio Girotto & Christophe Pascal & Jean-François Botton & Vincenzo Crupi - 820-830 Do Clinical Psychologists Extend the Bereavement Exclusion for Major Depression to Other Stressful Life Events?
by Nancy S. Kim & Daniel J. Paulus & Thao P. Nguyen & Jeffrey S. Gonzalez - 831-839 Information Distortion in Physicians’ Diagnostic Judgments
by Olga Kostopoulou & J. Edward Russo & Greg Keenan & Brendan C. Delaney & Abdel Douiri - 840-850 How Well Do Commonly Used Data Presentation Formats Support Comparative Effectiveness Evaluations?
by James G. Dolan & Feng Qian & Peter J. Veazie - 851-865 The Numeracy Understanding in Medicine Instrument
by Marilyn M. Schapira & Cindy M. Walker & Kevin J. Cappaert & Pamela S. Ganschow & Kathlyn E. Fletcher & Emily L. McGinley & Sam Del Pozo & Carrie Schauer & Sergey Tarima & Elizabeth A. Jacobs
September 2012, Volume 32, Issue 5
- 653-655 Note from the Editors
by Michael Drummond & Mark Helfand & C. Daniel Mullins - 656-659 Building Better Models
by Jeanne Mandelblatt & Clyde Schechter & David Levy & Ann Zauber & Yaojen Chang & Ruth Etzioni - 660-662 Transparently, with Validation
by Nancy Neil - 663-666 Transparency and Reproducible Research in Modeling
by Crystal M. Smith-Spangler - 667-677 Modeling Good Research Practices—Overview
by J. Jaime Caro & Andrew H. Briggs & Uwe Siebert & Karen M. Kuntz - 678-689 Conceptualizing a Model
by Mark Roberts & Louise B. Russell & A. David Paltiel & Michael Chambers & Phil McEwan & Murray Krahn - 690-700 State-Transition Modeling
by Uwe Siebert & Oguzhan Alagoz & Ahmed M. Bayoumi & Beate Jahn & Douglas K. Owens & David J. Cohen & Karen M. Kuntz - 701-711 Modeling Using Discrete Event Simulation
by Jonathan Karnon & James Stahl & Alan Brennan & J. Jaime Caro & Javier Mar & Jörgen Möller - 712-721 Dynamic Transmission Modeling
by Richard Pitman & David Fisman & Gregory S. Zaric & Maarten Postma & Mirjam Kretzschmar & John Edmunds & Marc Brisson - 722-732 Model Parameter Estimation and Uncertainty Analysis
by Andrew H. Briggs & Milton C. Weinstein & Elisabeth A. L. Fenwick & Jonathan Karnon & Mark J. Sculpher & A. David Paltiel - 733-743 Model Transparency and Validation
by David M. Eddy & William Hollingworth & J. Jaime Caro & Joel Tsevat & Kathryn M. McDonald & John B. Wong
July 2012, Volume 32, Issue 4
- 525-526 How Individual Genetic Test Disclosure May Affect Population Health
by Marilyn M. Schapira - 527-531 Looking at Patients’ Choices through the Lens of Expected Utility
by Louise B. Russell & Alan Schwartz - 532-544 The Influence of Graphic Display Format on the Interpretations of Quantitative Risk Information among Adults with Lower Education and Literacy
by Kirsten J. McCaffery & Ann Dixon & Andrew Hayen & Jesse Jansen & Sian Smith & Judy M. Simpson - 545-553 Tables or Bar Graphs? Presenting Test Results in Electronic Medical Records
by Noel T. Brewer & Melissa B. Gilkey & Sarah E. Lillie & Bradford W. Hesse & Stacey L. Sheridan - 554-568 Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D
by Matthijs M. Versteegh & Annemieke Leunis & Jolanda J. Luime & Mike Boggild & Carin A. Uyl-de Groot & Elly A. Stolk - 569-577 A Shortcut to Mean-Based Time Tradeoff Tariffs for the EQ-5D?
by Kim Rand-Hendriksen & Liv Ariane Augestad & Fredrik A. Dahl & Ivar Sønbø Kristiansen & Knut Stavem - 578-582 Valuing Health
by Paul Dolan & Robert Metcalfe - 583-593 A Direct Method for Measuring Discounting and QALYs More Easily and Reliably
by Arthur E. Attema & Han Bleichrodt & Peter P. Wakker - 594-605 Effectiveness of Personalized and Interactive Health Risk Calculators
by Christopher A. Harle & Julie S. Downs & Rema Padman - 606-615 Impact of Literacy and Numeracy on Motivation for Behavior Change After Diabetes Genetic Risk Testing
by Jason L. Vassy & Kelsey E. O’Brien & Jessica L. Waxler & Elyse R. Park & Linda M. Delahanty & Jose C. Florez & James B. Meigs & Richard W. Grant - 616-626 The Impact of Explicit Values Clarification Exercises in a Patient Decision Aid Emerges After the Decision Is Actually Made
by Deb Feldman-Stewart & Christine Tong & Rob Siemens & Shabbir Alibhai & Tom Pickles & John Robinson & Michael D. Brundage - 627-635 Serious Health Events and Discontinuation of Routine Cancer Screening
by David H. Howard & Ya-Lin Huang - 636-644 Perceptions of Shared Decision Making and Decision Aids Among Rural Primary Care Clinicians
by Valerie J. King & Melinda M. Davis & Paul N. Gorman & J. Bruin Rugge & L. J. Fagnan - 645-645 Parents Trust Other Parents
by Niels Haase & Cornelia Betsch
May 2012, Volume 32, Issue 3
- 1-10 Adaptation of Clinical Prediction Models for Application in Local Settings
by Teus H. Kappen & Yvonne Vergouwe & Wilton A. van Klei & Leo van Wolfswinkel & Cor J. Kalkman & Karel G. M. Moons - 11-21 Expected Net Present Value of Sample Information
by Peter S. Hall & Richard Edlin & Samer Kharroubi & Walter Gregory & Christopher McCabe - 22-33 Decision Coaching to Prepare Patients for Making Health Decisions
by Dawn Stacey & Jennifer Kryworuchko & Carol Bennett & Mary Ann Murray & Sarah Mullan & France Légaré - 397-399 Accounting for Biases When Linking Empirical Studies and Simulation Models
by Jeremy D. Goldhaber-Fiebert - 400-427 Policy Implications of Adjusting Randomized Trial Data for Economic Evaluations
by Nicole G. Campos & Philip E. Castle & Mark Schiffman & Jane J. Kim - 428-441 An Equity Framework for Health Technology Assessments
by Anthony J. Culyer & Yvonne Bombard - 442-446 Impact of Program Scale and Indirect Effects on the Cost-Effectiveness of Vaccination Programs
by Yoko Ibuka & A. David Paltiel & Alison P. Galvani - 447-458 Vaccinating to Help Ourselves and Others
by Jeffrey T. Vietri & Meng Li & Alison P. Galvani & Gretchen B. Chapman - 459-469 How Much Should We Pay for a New HIV Diagnosis? A Mathematical Model of HIV Screening in US Clinical Settings
by Paul G. Farnham & Stephanie L. Sansom & Angela B. Hutchinson - 470-476 Principles of Scarce Medical Resource Allocation in Natural Disaster Relief
by Hui Cao & Simin Huang - 477-487 Communicating Uncertainty in Economic Evaluations
by H. Koffijberg & G. A. de Wit & T. L. Feenstra - 488-497 Endogenous Patient Responses and the Consistency Principle in Cost-Effectiveness Analysis
by Liqun Liu & Andrew J. Rettenmaier & Thomas R. Saving - 498-506 Patient and Other Factors Influencing the Prescribing of Cardiovascular Prevention Therapy in the General Practice Setting With and Without Nurse Assessment
by Mohammed A. Mohammed & Charlotte El Sayed & Tom Marshall - 507-516 Do Different Methods of Modeling Statin Treatment Effectiveness Influence the Optimal Decision?
by Bob J. H. van Kempen & Bart S. Ferket & Albert Hofman & Sandra Spronk & Ewout Steyerberg & M. G. Myriam Hunink
March 2012, Volume 32, Issue 2
- 1-9 Bayesian Processing of Context-Dependent Text
by Farrokh Alemi & Manabu Torii & Martin J. Atherton & David C. Pattie & Kenneth L. Cox - 10-148 33rd Annual Meeting of the Society of Medical Decision Making
by N/A - 149-156 Author Index for Abstracts
by N/A - 225-226 Dichotomizing Continuous Variables in Statistical Analysis
by Neal V. Dawson & Robert Weiss - 227-231 A History of Evidence in Medical Decisions
by Dennis J. Mazur - 232-236 Measuring Risk Perceptions
by Wändi Bruine de Bruin & Katherine G. Carman - 237-245 Sponsorship-Related Outcome Selection Bias in Published Economic Studies of Triptans
by Piia K. Peura & Janne A. Martikainen & Timo T. Purmonen & Juha H. O. Turunen - 246-258 What Is Known about Parents’ Treatment Decisions? A Narrative Review of Pediatric Decision Making
by Ellen A. Lipstein & William B. Brinkman & Maria T. Britto - 259-265 How to Aggregate Health? Separability and the Effect of Framing
by Adam Turpcu & Han Bleichrodt & Quang A. Le & Jason N. Doctor - 266-272 A Quantitative Analysis of Optimal Treatment Capacity for Perinatal Asphyxia
by Alon Geva & James Gray - 273-286 Agreement about Identifying Patients Who Change over Time
by David Feeny & Karen Spritzer & Ron D. Hays & Honghu Liu & Theodore G. Ganiats & Robert M. Kaplan & Mari Palta & Dennis G. Fryback - 287-300 Creating Compact Comparative Health Care Information
by Olga C. Damman & Peter Spreeuwenberg & Jany Rademakers & Michelle Hendriks - 301-310 Crediting Treatments for Good Outcomes That Would Have Happened Anyway
by F. Vogt & D. Mason & T. M. Marteau - 311-326 Vulnerable Patients’ Perceptions of Health Care Quality and Quality Data
by Maria Catherine Raven & Colleen C. Gillespie & Rebecca DiBennardo & Kristin Van Busum & Brian Elbel - 327-336 Measuring Informed Decision Making about Prostate Cancer Screening in Primary Care
by Amy Leader & Constantine Daskalakis & Clarence H. Braddock III & Elisabeth J. S. Kunkel & James R. Cocroft & Sylvia Bereknyei & Jeffrey M. Riggio & Mark Capkin & Ronald E. Myers - 337-349 Optimization of PSA Screening Policies
by Jingyu Zhang & Brian T. Denton & Hari Balasubramanian & Nilay D. Shah & Brant A. Inman - 350-361 Developing Appropriate Methods for Cost-Effectiveness Analysis of Cluster Randomized Trials
by Manuel Gomes & Edmond S.-W. Ng & Richard Grieve & Richard Nixon & James Carpenter & Simon G. Thompson - 362-375 Heterogeneity of Cancer Patient Information-Seeking Behaviors
by Christel Protière & Nora Moumjid & Anne-Deborah Bouhnik & Anne Gaëlle Le Corroller Soriano & Jean Paul Moatti - 376-388 Bridging Health Technology Assessment (HTA) and Efficient Health Care Decision Making with Multicriteria Decision Analysis (MCDA)
by Mireille M. Goetghebeur & Monika Wagner & Hanane Khoury & Randy J. Levitt & Lonny J. Erickson & Donna Rindress
January 2012, Volume 32, Issue 1
- 1-12 Test Result–Based Sampling
by Patrick Taffé & Patricia Halfon & William A. Ghali & Bernard Burnand - 5-6 2011 Thank Reviewers Announcement
by N/A - 7-8 The Future of Health Technology Assessment
by Ahmed M. Bayoumi & Murray Krahn - 9-10 Measuring Health-Related Quality of Life
by Alan Schwartz - 11-30 Development and Validation of a Utility Weighting Function for the Patient-Oriented Prostate Utility Scale (PORPUS)
by George Tomlinson & Karen E. Bremner & Paul Ritvo & Gary Naglie & Murray D. Krahn - 13-19 Health Technology Assessment Implementation
by Daniel Callahan - 20-24 Health Technology Assessment
by Paul Glasziou - 25-32 Hic Sunt Dracones
by Anthony J. Culyer - 31-40 It’s All in the Name, or Is It? The Impact of Labeling on Health State Values
by Donna Rowen & John Brazier & Aki Tsuchiya & Tracey Young & Rachel Ibbotson - 41-55 Cross-Cultural Evaluation of the WHOQOL-BREF Domains in Primary Care Depressed Patients Using Rasch Analysis
by Neusa Sica Rocha & Mick J. Power & Donald M. Bushnell & Marcelo P. Fleck - 56-69 Regression Estimators for Generic Health-Related Quality of Life and Quality-Adjusted Life Years
by Anirban Basu & Andrea Manca - 70-82 Effect of Treatment Interruption and Intensification of Antiretroviral Therapy on Health-Related Quality of Life in Patients with Advanced HIV
by Vilija R. Joyce & Paul G. Barnett & Adam Chow & Ahmed M. Bayoumi & Susan C. Griffin & Huiying Sun & Mark Holodniy & Sheldon T. Brown & Tassos C. Kyriakides & D. William Cameron & Mike Youle & Mark Sculpher & Aslam H. Anis & Douglas K. Owens - 83-92 Efficacy of Phototherapy for Newborns with Hyperbilirubinemia
by Thomas B. Newman & Eric Vittinghoff & Charles E. McCulloch - 93-104 Factors Relating to Patient Visit Time With a Physician
by Alice W. Migongo & Richard Charnigo & Margaret M. Love & Richard Kryscio & Steven T. Fleming & Kevin A. Pearce - 105-117 Decision Making for HIV Prevention and Treatment Scale up
by Sabina S. Alistar & Margaret L. Brandeau - 118-131 Using Administrative Claims Data to Estimate Virologic Failure Rates among Human Immunodeficiency Virus–Infected Patients with Antiretroviral Regimen Switches
by Michael S. Broder & Timothy Juday & Eunice Y. Chang & Yonghua Jing & Tanya G. K. Bentley - 132-144 Exploring and Comparing the Characteristics of Nonlatent and Latent Composite Scores
by Tsung-Tai Chen & Mei-Shu Lai & I-Chin Lin & Kuo-Piao Chung - 145-153 Divergent Intentions to Use Antibiotic Guidelines
by Pieter-Jan Cortoos & Bert H. J. Schreurs & Willy E. Peetermans & Karel De Witte & Gert Laekeman